Effect of supplementation in treatment of patients with rheumatoid arthritis

Phase 3

• Conditions: Rheumatoid arthritis.; Other streptococcal arthritis and polyarthritis; M00.2

• Registration Number: IRCT201511015623N58
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with rheumatoid arthritis
Aged 25 to 70 years

Exclusion Criteria

Chronic renal failure
Renal tubular acidosis or pancreatitis
Patients likely to be started on biological agents
Pregnant or lactating women
Patients who are unable to read numbers and/or unable to mark the pain scale
Patients unlikely to come for follow-up in the following 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hs-CRP. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Elisa kit.;Nitric oxide. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Spectrophotometry.;DAS-28. Timepoint: At the beginning of the study and after 8 weeks of intervention. Method of measurement: Sum scores.